Eli Lilly
LLY
$737.20
Share price
0.50%
Change (1 day)
81.66%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Revenue for Eli Lilly (LLY)
Revenue in 2023 (TTM): $34.12 B
According to Eli Lilly's latest financial reports the company's current revenue (TTM) is $34.12 B. In 2022 the company made a revenue of $28.54 B an increase over the years 2021 revenue that were of $28.31 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Eli Lilly from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $34.12 B | 19.56% |
| 2022 | $28.54 B | 0.79% |
| 2021 | $28.31 B | 15.4% |
| 2020 | $24.53 B | 9.95% |
| 2019 | $22.31 B | 0.11% |
| 2018 | $22.29 B | -2.52% |
| 2017 | $22.87 B | 7.77% |
| 2016 | $21.22 B | 6.33% |
| 2015 | $19.95 B | 1.75% |
| 2014 | $19.61 B | -15.13% |
| 2013 | $23.11 B | 2.25% |
| 2012 | $22.60 B | -6.93% |
| 2011 | $24.28 B | 5.25% |
| 2010 | $23.07 B | 5.68% |
| 2009 | $21.83 B | 7.15% |
| 2008 | $20.37 B | 9.36% |
| 2007 | $18.63 B | 18.75% |
| 2006 | $15.69 B | 7.14% |
| 2005 | $14.64 B | 5.68% |
| 2004 | $13.85 B | 10.14% |
| 2003 | $12.58 B | 13.59% |
| 2002 | $11.07 B | -4.03% |
| 2001 | $11.54 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 172.60% | 🇺🇸 USA |
 Novartis NVS | $49.92 B | 46.30% | 🇨🇭 Switzerland |
 Pfizer PFE | $58.49 B | 71.42% | 🇺🇸 USA |
 AbbVie ABBV | $54.31 B | 59.18% | 🇺🇸 USA |
 Amgen AMGN | $28.19 B | -17.39% | 🇺🇸 USA |
 Sanofi SNY | $50.35 B | 47.58% | 🇫🇷 France |
 Merck MRK | $60.11 B | 76.16% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $45.53 B | 33.44% | 🇺🇸 USA |
 AstraZeneca AZN | $47.61 B | 39.52% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $37.84 B | 10.92% | 🇬🇧 UK |